Studies have shown conflicting roles for TREM2 in different cancers; while TREM2 is protective in HCC, it correlates with poor survival in colorectal carcinoma and triple-negative breast cancer (TNBC) [121, 122]. This evidence concerns the gene TREM2 and triple-negative breast carcinoma.